Delivery Order SPE2DB20D1109-SPE2DB25FN65A

Award Date 2/28/25
Potential Completion Date 3/3/25
Potential Value $6.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,370.39, is a Firm Fixed Price Delivery Order for the supply of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, a medical product. The contract has a period of performance through January 31, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, with a ceiling value of $5,226.40 and a completion date of January 8, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type, and there is no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML. The contract is a firm fixed-price delivery order with a ceiling value of $4,325.67 and a completion date of December 19, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth $999,999,999 through November 2026, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML medical supplies. The contract has a ceiling value of $8,069.52 and is a Firm Fixed Price Delivery Order without any set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, a medical product, with a ceiling value of $16,544.55 and a completion date of February 27, 2025. This delivery order contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML. The contract has a ceiling value of $12,972.80 and a period of performance through August 12, 2024. This award is not set aside for any specific business category. AmerisourceBergen, a major pharmaceutical distributor, holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999...
The Defense Logistics Agency (DLA) has awarded Amerisourcebergen Drug Corp, through its Corporate Office division, a firm fixed price delivery order contract worth $7,942.04 to provide VAXNEUVANCE 0.5 ML SYRINGE 0.5ML. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, which has a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,124.60, is for the delivery of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML medical supplies. The contract type is a Delivery Order with a Firm Fixed Price pricing mechanism, and the ultimate completion date is May 30, 2024. The contract is not designated with a set-aside requirement....
The federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,916.69, is for the delivery of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, a medical supply product, with a completion date of February 19, 2025. This appears to be a Firm Fixed Price delivery order contract, without any set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,602.34, is for the delivery of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, a vaccine product. This is a Firm Fixed Price Delivery Order contract with a completion date of May 9, 2024. The contract is not designated with a set-aside. AmerisourceBergen Drug Corp holds a $999,999,999...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB25FN65A
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML. The contract has a ceiling value of $6,851.95 and a period of performance through March 3, 2025. It is a firm fixed price delivery order contract with no set-aside designation, indicating open competition.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

Generated 5/30/25, 9:46 AM